Latest News

Uniseed Investee ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Fund Raise

ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Fund Raise
– Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051
– Company appoints President and Chief Scientific Officer of the COPD Foundation and respiratory therapy expert Ruth Tal-Singer, Ph.D. to Board of Directors

MEDIA ENQUIRIES
Interested in our investees?
Contact us.